InsiderClue
Insiders · Profile

Patel Sushil

Chief Executive Officer at Replimune · Director at Revolution Medicines. Filing since 16 May 2022. CIK 0001860609

REPL Replimune Group, Inc. Chief Executive Officer · 9 trades RVMD Revolution Medicines, Inc. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
REPL Replimune Group, Inc.
10 Aug 2026
Chief Executive Officer
Sold at will
39,341
$510.25K
5.3%
RVMD Revolution Medicines, Inc.
29 Jun 2026
Director
Sold on a plan
5,580
$1.05M
20.5%
REPL Replimune Group, Inc.
18 May 2026
Chief Executive Officer
Sold at will
37,324
$189.61K
4.8%
REPL Replimune Group, Inc.
2 Dec 2025
Chief Executive Officer
Sold on a plan
10,000
$111.30K
2.9%
REPL Replimune Group, Inc.
20 May 2025
Chief Executive Officer
Sold at will
25,105
$202.35K
6.8%
REPL Replimune Group, Inc.
16 Dec 2024
Chief Executive Officer
Sold on a plan
10,000
$124.20K
4.7%
RVMD Revolution Medicines, Inc.
31 Oct 2024
Director
Sold on a plan
5,000
$270.71K
20.0%
RVMD Revolution Medicines, Inc.
9 Jul 2024
Director
Sold on a plan
2,155
$94.82K
9.7%
REPL Replimune Group, Inc.
16 May 2024
Chief Executive Officer
Sold at will
20,194
$130.66K
8.7%
RVMD Revolution Medicines, Inc.
10 Apr 2024
Director
Sold on a plan
2,155
$79.74K
12.1%
REPL Replimune Group, Inc.
13 Jun 2023
Chief Strategy Officer
Sold on a plan
5,698
$137.01K
3.7%
REPL Replimune Group, Inc.
16 May 2023
Chief Strategy Officer
Sold at will
15,575
$281.13K
9.2%
REPL Replimune Group, Inc.
16 May 2022
Chief Commercial Officer
Sold, plan not stated
10,687
$155.92K
7.6%
13 decisions on file.